Using Electrical Cardiometry and Ultrasound of the Inferior Vena Cava to Predict Fluid Responsiveness in Adults with Septic Shock

What this Trial Is About

Sepsis is a life-threatening condition caused by an abnormal response to infection, leading to organ failure. Septic shock is a severe type of sepsis marked by persistent low blood pressure and metabolic problems despite fluid treatment. This study aims to compare methods for predicting fluid responsiveness in patients with septic shock to improve individualized fluid therapy and prevent complications like fluid overload. Accurate prediction is especially important since traditional measures can be unreliable in diverse patient situations. The study evaluates two non-invasive methods electrical cardiometry and ultrasound assessment of the inferior vena cava IVC collapsibility. Electrical cardiometry uses advanced bioimpedance technology to measure stroke volume and cardiac output without invasive procedures. The IVC collapsibility index is measured via bedside ultrasound during the respiratory cycle. Both are assessed at baseline and after fluid challenge to monitor fluid responsiveness in critically ill patients. Participants diagnosed with hypotensive sepsis will be monitored using these non-invasive techniques as part of routine clinical care without changing their treatment. Researchers will collect data on septic shock parameters over two hours to evaluate fluid responsiveness. The study includes clinical assessments, ultrasound measurements, and hemodynamic monitoring to help guide fluid management. Participation involves standard care monitoring and non-invasive measurements during the critical illness period.

Comparison Between Using Cardiometry and IVC Collapsibility